ParkinsonFranceV1, PubMed, Corpus, bibRecord, 000A09

Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.

Identifieur interne : 000A09 ( PubMed/Corpus ); précédent : 000A08; suivant : 000A10

Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.

Auteurs : Guylaine Hoffner ; Amandine Vanhoutteghem ; William André ; Philippe Djian

Source :

Advances in enzymology and related areas of molecular biology [ 0065-258X ] ; 2011.

RBID : pubmed:22220473

English descriptors

KwdEn :
- Alzheimer Disease (etiology), Alzheimer Disease (genetics), Alzheimer Disease (metabolism), Animals, Cross-Linking Reagents (metabolism), Epidermis (cytology), Epidermis (metabolism), Epidermis (physiology), Humans, Keratinocytes (metabolism), Keratinocytes (physiology), Nervous System Diseases (etiology), Nervous System Diseases (genetics), Nervous System Diseases (metabolism), Parkinson Disease (etiology), Parkinson Disease (genetics), Parkinson Disease (metabolism), Peptides (metabolism), Substrate Specificity, Transglutaminases (genetics), Transglutaminases (metabolism), Transglutaminases (physiology).
MESH :
- chemical , genetics : Transglutaminases.
- chemical , metabolism : Cross-Linking Reagents, Peptides, Transglutaminases.
- cytology : Epidermis.
- etiology : Alzheimer Disease, Nervous System Diseases, Parkinson Disease.
- genetics : Alzheimer Disease, Nervous System Diseases, Parkinson Disease.
- metabolism : Alzheimer Disease, Epidermis, Keratinocytes, Nervous System Diseases, Parkinson Disease.
- physiology : Epidermis, Keratinocytes, Transglutaminases.
- Animals, Humans, Substrate Specificity.

PubMed: 22220473

Links to Exploration step

pubmed:22220473

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.</title>
<author><name sortKey="Hoffner, Guylaine" sort="Hoffner, Guylaine" uniqKey="Hoffner G" first="Guylaine" last="Hoffner">Guylaine Hoffner</name>
<affiliation><nlm:affiliation>Unité Propre de Recherche 2228 du Centre National de la Recherche Scientifique, Régulation de la Transcription et Maladies Génétiques, Université Paris Descartes, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vanhoutteghem, Amandine" sort="Vanhoutteghem, Amandine" uniqKey="Vanhoutteghem A" first="Amandine" last="Vanhoutteghem">Amandine Vanhoutteghem</name>
</author>
<author><name sortKey="Andre, William" sort="Andre, William" uniqKey="Andre W" first="William" last="André">William André</name>
</author>
<author><name sortKey="Djian, Philippe" sort="Djian, Philippe" uniqKey="Djian P" first="Philippe" last="Djian">Philippe Djian</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:22220473</idno>
<idno type="pmid">22220473</idno>
<idno type="wicri:Area/PubMed/Corpus">000A09</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A09</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.</title>
<author><name sortKey="Hoffner, Guylaine" sort="Hoffner, Guylaine" uniqKey="Hoffner G" first="Guylaine" last="Hoffner">Guylaine Hoffner</name>
<affiliation><nlm:affiliation>Unité Propre de Recherche 2228 du Centre National de la Recherche Scientifique, Régulation de la Transcription et Maladies Génétiques, Université Paris Descartes, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vanhoutteghem, Amandine" sort="Vanhoutteghem, Amandine" uniqKey="Vanhoutteghem A" first="Amandine" last="Vanhoutteghem">Amandine Vanhoutteghem</name>
</author>
<author><name sortKey="Andre, William" sort="Andre, William" uniqKey="Andre W" first="William" last="André">William André</name>
</author>
<author><name sortKey="Djian, Philippe" sort="Djian, Philippe" uniqKey="Djian P" first="Philippe" last="Djian">Philippe Djian</name>
</author>
</analytic>
<series><title level="j">Advances in enzymology and related areas of molecular biology</title>
<idno type="ISSN">0065-258X</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer Disease (etiology)</term>
<term>Alzheimer Disease (genetics)</term>
<term>Alzheimer Disease (metabolism)</term>
<term>Animals</term>
<term>Cross-Linking Reagents (metabolism)</term>
<term>Epidermis (cytology)</term>
<term>Epidermis (metabolism)</term>
<term>Epidermis (physiology)</term>
<term>Humans</term>
<term>Keratinocytes (metabolism)</term>
<term>Keratinocytes (physiology)</term>
<term>Nervous System Diseases (etiology)</term>
<term>Nervous System Diseases (genetics)</term>
<term>Nervous System Diseases (metabolism)</term>
<term>Parkinson Disease (etiology)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Peptides (metabolism)</term>
<term>Substrate Specificity</term>
<term>Transglutaminases (genetics)</term>
<term>Transglutaminases (metabolism)</term>
<term>Transglutaminases (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Transglutaminases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cross-Linking Reagents</term>
<term>Peptides</term>
<term>Transglutaminases</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Epidermis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Alzheimer Disease</term>
<term>Nervous System Diseases</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Alzheimer Disease</term>
<term>Nervous System Diseases</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Alzheimer Disease</term>
<term>Epidermis</term>
<term>Keratinocytes</term>
<term>Nervous System Diseases</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Epidermis</term>
<term>Keratinocytes</term>
<term>Transglutaminases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
<term>Substrate Specificity</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22220473</PMID>
<DateCreated><Year>2012</Year>
<Month>01</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>02</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>05</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-258X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>78</Volume>
<PubDate><Year>2011</Year>
</PubDate>
</JournalIssue>
<Title>Advances in enzymology and related areas of molecular biology</Title>
<ISOAbbreviation>Adv. Enzymol. Relat. Areas Mol. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.</ArticleTitle>
<Pagination><MedlinePgn>97-160</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoffner</LastName>
<ForeName>Guylaine</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Unité Propre de Recherche 2228 du Centre National de la Recherche Scientifique, Régulation de la Transcription et Maladies Génétiques, Université Paris Descartes, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vanhoutteghem</LastName>
<ForeName>Amandine</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>André</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Djian</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Adv Enzymol Relat Areas Mol Biol</MedlineTA>
<NlmUniqueID>0337243</NlmUniqueID>
<ISSNLinking>0065-258X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003432">Cross-Linking Reagents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>26700-71-0</RegistryNumber>
<NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.3.2.13</RegistryNumber>
<NameOfSubstance UI="D011503">Transglutaminases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003432" MajorTopicYN="N">Cross-Linking Reagents</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004817" MajorTopicYN="N">Epidermis</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015603" MajorTopicYN="N">Keratinocytes</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011503" MajorTopicYN="N">Transglutaminases</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>1</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>2</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22220473</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A09 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000A09 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:22220473
   |texte=   Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:22220473" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.

Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki